X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
HUL: Time for a different strategy? - Views on News from Equitymaster
 
 
  • PRINT
  • E-MAIL
  • FEEDBACK
  • A  A  A
  • Jul 21, 2009

    HUL: Time for a different strategy?

    Hindustan Unilever Limited (HUL) witnessed a revenue growth of 6% YoY for the March 2009 quarter. Although the March quarter is a slow one for the company and is coming off a high base with 18% growth recorded for March 2008 quarter, A C Nielsen data shows that this is due to loss of market share in key product categories.

    In the last year, HUL lost more than 600 basis points in market share in personal wash (54.3% to 48.2%), 340 basis points in skin care (55.4% to 52%) and 150 basis points in toothpaste (29.5% to 28%). This loss is attributed to HUL's focus on high-value products, consumers switching to cheaper regional brands, lack of product innovations and stable pricing by rivals.

    In the face of slowdown, HUL's strategy to maintain margins was to focus on premium brands like Ponds and Dove since the demand for these products was perceived to be price inelastic. However, the consumers were hunting for value offers during this period.

    The main competitors for HUL who have gained market share at its expense are Godrej and Reckitt Benckiser in soaps, Colgate and Dabur in oral care and Dabur in Shampoos.

    Moreover regional companies like Chik in shampoos, Dyna and Santoor in soaps and Nirma and Ghadi in detergents gave incentives to trade by increasing trade margins and increasing the credit period, hurting HUL further.

    HUL had stated recently that it is concentrating on regaining its market share going forward as it believes that without market share, profitability is impossible. The company has already started putting a strategy in place which includes grammage correction, pricing unit packs at lower price points and increasing promotions for value brands. Under the grammage correction, Wheel soap's Rs.10 pack was increased by 25 gms to 275 gms while Lux soap's Rs.18 pack now weighs 25 gms more than earlier. HUL also hiked retailer margins in some categories, offering 8% incremental margins. The company is reducing the prices of its detergent brands like Wheel and Surf and is investing heavily on brands like Rexona, Breeze and Hamam.

    We believe that HUL's focus on market share will benefit the company as in the scenario of low inflation, growth will come from volumes. However, we would like to wait and watch how the competitors react to HUL's strategy.

     

     

    Equitymaster requests your view! Post a comment on "HUL: Time for a different strategy?". Click here!

      
     

    More Views on News

    GSK Consumer: On the Recovery Path (Quarterly Results Update - Detailed)

    Jun 20, 2017

    While GSK consumer reported muted revenue growth, volumes are seen to be recovering.

    Apex frozen food Ltd. (IPO)

    Aug 21, 2017

    Should you subscribe to the IPO of Apex Frozen Foods Ltd?

    HUL: A Slow End to a Dull Year... (Quarterly Results Update - Detailed)

    May 9, 2016 | Updated on May 11, 2016

    HUL announced its results for the quarter and year ended March 2016. While revenues rose by 4% YoY, net profits increased by 7% YoY.

    Hindustan Unilever: Deflationary Pressures Curb Growth (Quarterly Results Update - Detailed)

    Jan 21, 2016

    HUL announced its results for the quarter ended December 2015. While revenues were up by 3% YoY, profits came in lower by 22% YoY.

    Hindustan Unilever: Fails to meet expectations (Quarterly Results Update - Detailed)

    Oct 16, 2015

    HUL announced its results for the quarter ended September 2015. While revenues were up by 4% YoY, profits came in lower by 3% YoY.

    More Views on News

    Most Popular

    This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

    Aug 17, 2017

    A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

    The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

    Aug 10, 2017

    Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

    Signs of Life in the India VIX(Daily Profit Hunter)

    Aug 12, 2017

    The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

    Bitcoin Continues Stellar Rise(Chart Of The Day)

    Aug 10, 2017

    Bitcoin hits an all-time high, is there more upside left?

    5 Steps To Become Financially Independent(Outside View)

    Aug 16, 2017

    Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

    More
    Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
    Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

    LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

    SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

    Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
    Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
     

    Become A Smarter Investor In
    Just 5 Minutes

    Multibagger Stocks Guide 2017
    Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
    We will never sell or rent your email id.
    Please read our Terms

    HIND. UNILEVER SHARE PRICE


    Aug 22, 2017 (Close)

    TRACK HIND. UNILEVER

    • Track your investment in HIND. UNILEVER with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
    • Add To MyStocks

    MORE ON HIND. UNILEVER

    HIND. UNILEVER - P&G COMPARISON

    Compare Company With Charts

    COMPARE HIND. UNILEVER WITH

    MARKET STATS